[HTML][HTML] Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent, M Rosa-Calatrava… - Current Opinion in …, 2022 - Elsevier
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

[PDF][PDF] Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent… - Current Opinion in …, 2022 - binasss.sa.cr
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent… - Current opinion in …, 2022 - pubmed.ncbi.nlm.nih.gov
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

[HTML][HTML] Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent… - Current Opinion in …, 2022 - ncbi.nlm.nih.gov
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

Treatments for COVID-19: Lessons from 2020 and new therapeutic options.

F Salasc, T Lahlali, E Laurent… - Current Opinion in …, 2021 - europepmc.org
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

Treatments for COVID-19: lessons from 2020 and new therapeutic options.

F Salasc, E Laurent, M Rosa-Calatrava, T Lahlali… - 2022 - cabidigitallibrary.org
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …